Year archive

Valneva SE — 2026 filings

All 57 regulatory filings released by Valneva SE (VLA) in 2026, sourced directly from the official regulator.

57 Filings

2026 Period

2026 filings (57)

Filing	Released	Lang
6-K Regulatory Filings	2026-06-05	English
Valneva annonce la mise à disposition de la documentation relative à son Assemblée Générale annuelle Report Publication Announcement	2026-06-04	French
Valneva Announces Availability of Documentation for its Annual General Meeting Regulatory Filings	2026-06-04	English
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 31 mai 2026 Regulatory Filings	2026-06-03	French
VALNEVA:Declaration of shares and voting rights - Status as of May 31, 2026 Regulatory Filings	2026-06-03	English
6-K Regulatory Filings	2026-06-01	English
Valneva to Participate at U.S. and European Investor Conferences in June Regulatory Filings	2026-05-28	English
Valneva annonce sa participation à des conférences investisseurs aux États-Unis et en Europe Regulatory Filings	2026-05-28	French
Franchissement de seuil Major Shareholding Notification	2026-05-28	French
6-K - Valneva SE (0001836564) (Filer) Regulatory Filings	2026-05-13	English
Valneva publie ses résultats financiers audités et consolidés pour le premier trimestre 2026 Earnings Release Q1 2026	2026-05-13	French
Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates Earnings Release Q1 2026	2026-05-13	English
Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 Earnings Release Q1 2026	2026-05-06	English
Valneva publiera ses résultats financiers consolidés du premier trimestre le 13 mai 2026 Earnings Release Q1 2026	2026-05-06	French
VALNEVA: Declaration of shares and voting rights - Status as of April 30, 2026 taking into account interim information as at May 5, 2026 Major Shareholding Notification	2026-05-05	English
VALNEVA : Déclaration d’actions et de droits de vote - Statut au 30 avril 2026 tenant compte d’informations intermédiaires au 5 mai 2026 Major Shareholding Notification	2026-05-05	French
6-K - Valneva SE (0001836564) (Filer) Regulatory Filings	2026-05-05	English
Valneva publiera ses résultats financiers consolidés du premier semestre le 13 mai 2026 Report Publication Announcement	2026-05-05	French
Valneva to Report First Quarter 2026 Consolidated Financial Results on May 13, 2026 Report Publication Announcement	2026-05-05	English
Valneva Announces the Successful Completion of an €84 million Reserved Offering Capital/Financing Update	2026-04-30	English
Valneva annonce le succès d’une Offre Réservée d’un montant de 84 millions d’euros Capital/Financing Update	2026-04-30	French
Déclaration d'actions et de droits de vote de la société Valneva SE - Mars 2026 Major Shareholding Notification	2026-04-03	French
Declaration of shares and voting rights of Valneva SE – March 2026 Declaration of Voting Results & Voting Rights Announcements	2026-04-03	English
6-K - Valneva SE (0001836564) (Filer) Regulatory Filings	2026-03-26	English
Valneva to Participate in Multiple Events at the 26th World Vaccine Congress in Washington DC Regulatory Filings	2026-03-26	English
Valneva participera à plusieurs événements lors du 25ème World Vaccine Congress de Washington Regulatory Filings	2026-03-26	French
Pfizer et Valneva annoncent que le candidat vaccin contre la maladie de Lyme démontre une forte efficacité dans l’essai de Phase 3 VALOR Regulatory Filings	2026-03-23	French
6-K - Valneva SE (0001836564) (Filer) Regulatory Filings	2026-03-18	English
Valneva Reports Full Year 2025 Audited Consolidated Financial Results Earnings Release FY 2025	2026-03-18	English
Valneva publie ses résultats financiers audités et consolidés pour l’exercice 2025 Earnings Release FY 2025	2026-03-18	French
Document d'enregistrement universel 2025 Annual Report (ESEF) FY 2025	2026-03-17	French
Valneva publiera ses résultats financiers consolidés 2025 le 18 mars 2026 Report Publication Announcement	2026-03-09	French
Valneva to Report Full Year 2025 Consolidated Financial Results on March 18, 2026 Report Publication Announcement	2026-03-09	English
VALNEVA Déclaration d’actions et de droits de vote : 28 février 2026 Regulatory Filings	2026-03-06	French
VALNEVA Declaration of shares and voting rights: February 28, 2026 Declaration of Voting Results & Voting Rights Announcements	2026-03-06	English
Valneva annonce sa participation à des conférences investisseurs Investor Presentation	2026-03-02	French
Valneva to Participate in Upcoming Investor Conferences Regulatory Filings	2026-03-02	English
Valneva Reports Preliminary Unaudited 2025 Revenue and Cash and Provides 2026 Outlook Earnings Release FY 2025	2026-02-19	English
Valneva publie son chiffre d’affaires et sa trésorerie non audités pour l’exercice 2025 et fournit ses prévisions pour l’exercice 2026 Earnings Release FY 2025	2026-02-19	French
Valneva fait un point sur l’utilisation du vaccin IXCHIQ® au Royaume-Uni Regulatory Filings	2026-02-13	French
Valneva Provides Update on Recommendations for Use of IXCHIQ® in the United Kingdom Regulatory Filings	2026-02-13	English
6-K Filing Regulatory Filings	2026-02-13	English
VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026 Share Issue/Capital Change	2026-02-11	French
VALNEVA Declaration of shares and voting rights: January 31, 2026 Share Issue/Capital Change	2026-02-11	English
VALNEVA Déclaration d’actions et de droits de vote : 31 janvier 2026 Regulatory Filings	2026-02-06	French
VALNEVA Declaration of shares and voting rights: January 31, 2026 Share Issue/Capital Change	2026-02-06	English
Valneva et l'Instituto Butantan annoncent le début d'une stratégie pilote de vaccination au Brésil avec le vaccin à injection unique IXCHIQ® contre le chikunguny Regulatory Filings	2026-02-03	French
Valneva and Instituto Butantan Announce Initiation of a Pilot Vaccination Campaign in Brazil with Single-Shot Chikungunya Vaccine IXCHIQ® Regulatory Filings	2026-02-03	English
6-K Filing Regulatory Filings	2026-02-03	English
6-K Regulatory Filings	2026-01-20	English
Valneva Provides Update on Chikungunya Vaccine IXCHIQ® Regulatory Filings	2026-01-19	English
Valneva fait un point sur son vaccin contre le chikungunya IXCHIQ® Earnings Release FY 2026	2026-01-19	French
6-K Regulatory Filings	2026-01-09	English
Valneva rencontrera des investisseurs lors de la J.P. Morgan Healthcare Conference Investor Presentation	2026-01-09	French
Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference Regulatory Filings	2026-01-09	English
Valneva SE - Declaration of voting rights - December 2025 Declaration of Voting Results & Voting Rights Announcements	2026-01-08	English
Déclaration d'actions et de droits de vote de la société Valneva SE - décembre 2025 Declaration of Voting Results & Voting Rights Announcements	2026-01-08	French

Filings by year

2026 57 filings
2025 157 filings
2024 156 filings
2023 131 filings
2022 206 filings
2021 225 filings
2020 62 filings
2019 86 filings
2018 31 filings
2017 44 filings
2016 63 filings
2015 61 filings
2014 44 filings
2013 90 filings
2012 75 filings
2011 60 filings
2010 51 filings
2009 61 filings
2008 10 filings